Hermes Addition will Enhance Services for Academic Medical Centers, Research Institutions, and Drug and Device Companies
Nashville, Tenn., (February 20, 2020) – Bass, Berry & Sims is pleased to announce the addition of Clint D. Hermes as counsel to its nationally ranked Healthcare Practice Group, focusing on regulatory and contracting aspects of biomedical research.
Hermes brings extensive, in-house experience at academic medical centers with large research programs and an international footprint. In his most recent role, Hermes was General Counsel and Board Secretary of Sidra Medicine, an academic medical center in Doha, Qatar, affiliated with Cornell University. Before that, Hermes was Senior Vice President and Chief Legal Officer at St. Jude Children’s Research Hospital. His duties in those roles included leading legal affairs, technology transfer and licensing, ethics and compliance, board management, and an Institutional Review Board.
Hermes has helped create many productive research partnerships by structuring contracts to carry out a clinical trial or other research collaboration among various parties, whether across the country or around the world. He has particular experience assisting U.S. institutions structure and implement healthcare, research, education, and humanitarian projects overseas, and advised on both legal and practical considerations informed by his travel and work across Africa, Asia, the Middle East, North America and South America.
“Clint has dedicated his practice to helping researchers create and test the innovations that continue to drive healthcare forward,” said Angela Humphreys, chair of the Healthcare Practice Group. “Clint’s deep knowledge of biomedical research will enhance our service of academic medical centers and other research institutions, as well as drug and device manufacturers, contract research organizations, and others in the clinical trial space.”
Hermes is a widely published author on biomedical research regulatory matters involving the Common Rule, INDs and IDEs, conflicts of interest, research misconduct, NIH grant funding, the use and sharing of research data and biospecimens, and human research protection program design and implementation. He also is a member of the American Health Lawyers Association (AHLA) and Public Responsibility in Medicine & Research (PRIM&R).
“I am excited to join one of the largest, most prestigious healthcare law practice groups in the country, with so many deeply knowledgeable healthcare attorneys,” Hermes said. “Bass, Berry & Sims has a practical approach to advising clients on reaching their clinical and business goals that mirrors the way I have practiced my entire career. I’m also looking forward to collaborating with my peers to work with the firm’s international and higher education clients on issues related to foreign research funding, export controls, and academic research issues.”
Hermes will be based in the firm’s Knoxville office.
Prior to his in-house leadership roles, Hermes was an attorney with international law firm Ropes & Gray LLP where he advised many of the top academic medical centers, pharmaceutical companies and device companies across the country on research collaborations, research regulation and funding, international programs, nonprofit governance, compliance program design and implementation, HIPAA, and conflicts of interest.
Hermes graduated from Harvard Law School and earned his bachelor’s degree from Yale University.
About Bass, Berry & Sims PLC
With more than 280 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims has been involved in some of the largest and most significant litigation matters, investigations and business transactions in the country. Our attorneys work seamlessly across substantive practice disciplines, industries and geographies to deliver highly effective service and business-focused solutions. For more information, visit www.bassberry.com.